CEimpact Podcast
The CEimpact Podcast features two shows - GameChangers and Precept2Practice!
The GameChangers Clinical Conversations podcast, hosted by Josh Kinsey, features the latest game-changing pharmacotherapy advances impacting patient care. New episodes arrive every Monday. Pharmacist By Design™ subscribers can earn CE credit for each episode.
The Precept2Practice podcast, hosted by Kathy Schott, features information and resources for preceptors of students and residents. New episodes arrive on the third Wednesday of every month. Preceptor By Design™ subscribers can earn CE credit for each episode.
To support our shows, give us a follow and check back each week for our latest episodes.
CEimpact Podcast
Semaglutide or Liraglutide for Weight Loss?
Weight gain can impact patient’s quality of life and put them at risk for health complications. While weight loss can be an important factor in a patient’s health, it is equally important that it is done safely and effectively. Listen in as host, Geoff Wall compares the safety and efficacy of semaglutide and liraglutide in weight loss.
The GameChanger:
- Based on a recent Phase-3 study, semaglutide appears to be more effective in weight loss than liraglutide
- Semaglutide also appeared to have modest effects on decreasing systolic blood pressure, blood sugar, lipid concentrations, and serum insulin levels
- GLP-1 agonists are expensive medications – patients should be made aware of the of the associated cost as a part of patient centered care
Show Segments:
00:00 – Introductions
01:10 – GLP-1s Agonist (Semaglutide vs Liraglutide) in Weight Management
10:00 – Change in Body Weight
12:02 – Secondary Outcomes – Blood Pressure, Blood Sugar, Lipid Concentrations, & Serum Insulin
12:59 – Safety & Side Effects
14:15 – Cost
14:52 – The GameChanger
17:20 – Closing Remarks
Links to Resources:
How to Claim CE:
CE is available for CEimpact members:
· Click here to claim CPE Credit
· Click here to claim CME Credit
Need a membership?
Continuing Education Information:
Learning Objectives:
1. Describe the inclusion and exclusion criteria of the STEP 8 study
2. Discuss the outcomes of the STEP 8 study
Dr. Wall is a member of the Janssen Speaker's Bureau.
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-088-H01-P
Initial release date: 02/14/22
Expiration date: 02/14/2023
Additional CPE & CME details can be found here"